GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (OTCPK:VPTDF) » Definitions » Gross Profit

VPTDF (VentriPoint Diagnostics) Gross Profit : $0.10 Mil (TTM As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is VentriPoint Diagnostics Gross Profit?

VentriPoint Diagnostics's gross profit for the three months ended in Sep. 2024 was $0.05 Mil. VentriPoint Diagnostics's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $0.10 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. VentriPoint Diagnostics's gross profit for the three months ended in Sep. 2024 was $0.05 Mil. VentriPoint Diagnostics's Revenue for the three months ended in Sep. 2024 was $0.05 Mil. Therefore, VentriPoint Diagnostics's Gross Margin % for the quarter that ended in Sep. 2024 was N/A%.

VentriPoint Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of VentriPoint Diagnostics was 85.71%. The lowest was -25.49%. And the median was 43.33%.


VentriPoint Diagnostics Gross Profit Historical Data

The historical data trend for VentriPoint Diagnostics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Gross Profit Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 - 0.04 0.03

VentriPoint Diagnostics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 0.03 - 0.02 0.05

Competitive Comparison of VentriPoint Diagnostics's Gross Profit

For the Medical Devices subindustry, VentriPoint Diagnostics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Gross Profit distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Gross Profit falls into.


;
;

VentriPoint Diagnostics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

VentriPoint Diagnostics's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.037 - 0.006
=0.03

VentriPoint Diagnostics's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=0.048 - 0
=0.05

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

VentriPoint Diagnostics's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.05 / 0.048
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


VentriPoint Diagnostics  (OTCPK:VPTDF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

VentriPoint Diagnostics had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


VentriPoint Diagnostics Gross Profit Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.

VentriPoint Diagnostics Headlines

From GuruFocus